Sublicense Conditions. The Company’s right to sublicense granted by Penn under the License is subject to each of the following conditions:
Sublicense Conditions. The right to sublicense granted to Licensee under Section 2.1 is subject to the following conditions:
Sublicense Conditions. Company’s right to extend any or all of the rights granted to Company by Cellscript via a sublicense to affiliates or Third Parties is subject to each of the following conditions:
Sublicense Conditions. ASOthera’s right to grant Sublicenses under the Licenses is subject to each of the following conditions:
Sublicense Conditions. Audentes acknowledges and agrees that Audentes’s rights in this Agreement are subject to the terms and conditions of the HHS Patent License Agreement. In particular, and without limitation, in accordance with paragraph 4.2 thereof, Genethon’s obligations to PHS set out in paragraphs 5.1, 7.1, 9.1, 9.2, 11, 12.4 and 13.6-13.7 of the HHS Patent License Agreement shall be binding upon Audentes as if Audentes were a party thereto (i.e., for the purposes hereof, Audentes shall be deemed to be the “Licensee” referred to in these paragraphs). Copies of such paragraphs are set out in Exhibit A hereto.
Sublicense Conditions. The Company’s right to sublicense granted by Rockefeller under the License is subject to each of the following conditions:
Sublicense Conditions. The Company’s right to sublicense granted by Drexel under the License is subject to each of the following conditions:
Sublicense Conditions. The Company’s right to sublicense any aspects granted by PSRF under the License is subject to each of the following conditions:
Sublicense Conditions. Company’s right to extend any or all of the rights granted to Company by mRNA RiboTherapeutics via a sublicense to affiliates or Third Parties is subject to each of the following conditions:
Sublicense Conditions. The VGX’s right to sublicense granted by Penn under the License is subject to each of the following conditions:
